NOT KNOWN FACTUAL STATEMENTS ABOUT PALBOCICLIB

lumacaftor/ivacaftor will minimize the level or impact of abemaciclib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Coadministration of abemaciclib with strong CYP3A4 inducers minimizes plasma concentration of abemaciclib and its metabolites.Cell proliferation was assessed employing a bromodeoxyurid